RTP Mobile Logo
Select Publications

Ascierto PA et al. Pyrexia-related outcomes upon application of an adapted pyrexia management algorithm in patients (pts) with BRAF V600: Mutant unresectable or metastatic melanoma treated with dabrafenib plus trametinib (DabTram) in the COMBI-i trial. ASCO 2021;Abstract 9560.

Brase JC et al. Role of tumor-infiltrating B cells in clinical outcome of patients with melanoma treated with dabrafenib plus trametinib. Clin Cancer Res 2021;27(16):4500-10. Abstract

Cho KK et al. Metastatic acral melanoma treatment outcomes: A systematic review and meta-analysis. Melanoma Res 2021;31(5):482-6. Abstract

Dummer R et al. Five-year overall survival (OS) in COLUMBUS: A randomized phase 3 trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients (pts) with BRAF V600-mutant melanoma. ASCO 2021;Abstract 9507.

Ferrucci PF et al. KEYNOTE-022 International Team. KEYNOTE-022 part 3: A randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma. J Immunother Cancer 2020;8(2):e001806. Abstract

Hong AM et al. Management of melanoma brain metastases: Evidence-based clinical practice guidelines by Cancer Council Australia. Eur J Cancer 2021;142:10-7. Abstract

Li AT et al. Survival outcomes of salvage metastasectomy after failure of modern-era systemic therapy for melanoma. Ann Surg Oncol 2021;28(11):6109-23. Abstract

Long G. Making progress against melanoma: Historical perspective. General Session. ASCO 2021. https://meetinglibrary.asco.org/record/193765/video

Rabbie R et al. The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence. Br J Cancer 2021;124(1):156-60. Abstract

Schadendorf D et al. Pyrexia in patients treated with dabrafenib plus trametinib across clinical trials in BRAF-mutant cancers. Eur J Cancer 2021;153:234-41. Abstract

Syeda MM et al. Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: A clinical validation study. Lancet Oncol 2021;22(3):370-80. Abstract

Tawbi HA et al. Treatment outcomes in patients (pts) with melanoma brain metastases (MBM) treated with systemic therapy: A systematic literature review (SLR) and meta-analysis. ASCO 2021;Abstract 9561.